Putnam BioRevolution ETF (SYNB)

Assets	$5.35M
Expense Ratio	0.70%
PE Ratio	26.19
Shares Out	175,000
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Ratio	n/a
1-Year Return	+15.74%

Volume	25
Open	30.96
Previous Close	30.61
Day's Range	30.61 - 30.87
52-Week Low	24.47
52-Week High	31.15
Beta	n/a
Holdings	36
Inception Date	Sep 29, 2022

About SYNB

Fund Home Page

The Putnam BioRevolution ETF (SYNB) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund actively invests in companies of all sizes around the globe that enable biological innovation. SYNB was launched on Sep 29, 2022 and is issued by Putnam.

• Asset Class: Equity
• Stock Exchange: NYSEARCA
• Ticker Symbol: SYNB
• ETF Provider: Putnam

Top 10 Holdings

54.23% of assets

Name	Symbol	Weight
Thermo Fisher Scientific Inc.	TMO	7.84%
Danaher Corporation	DHR	7.28%
NVIDIA Corporation	NVDA	6.98%
Alphabet Inc.	GOOGL	6.23%
Bio-Rad Laboratories, Inc.	BIO	5.29%
Corteva, Inc.	CTVA	4.57%
Novonesis AS ADR	NVZMY	4.44%
AbbVie Inc.	ABBV	4.00%
Ascendis Pharma A/S	ASND	3.80%
Eli Lilly and Company	LLY	3.79%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 6, 2023	$0.0211	Dec 11, 2023